William Blair & Company’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ASTH
William Blair & Company's ASTH Position: Q3 2026 in Review
William Blair & Company reduced its Astrana Health (ASTH) stake by 12% in Q3 2026, selling an estimated $130K and leaving 23,394 shares worth $832K. The position accounts for ﹤0.01% of the portfolio, ranked #1021.
William Blair & Company first reported a position in ASTH in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.24M in Q2 2026. 218 funds tracked by Wall St. Rank hold ASTH as of Q3 2026.
- William Blair & Company held 23,394 shares of Astrana Health worth $832K as of Q3 2026.
- William Blair & Company sold 3,292 Astrana Health shares in Q3 2026, an estimated $130K.
- Astrana Health made up ﹤0.01% of William Blair & Company's portfolio in Q3 2026, its #1021 holding.
- William Blair & Company first reported a position in Astrana Health in Q4 2025 and has held it in 4 quarters since.
- William Blair & Company's Astrana Health position peaked at $1.24M in Q2 2026.
- 218 funds tracked by Wall St. Rank held Astrana Health as of Q3 2026.
Based on William Blair & Company's 13F filing for Q3 2026, filed 10 Nov 2026.